205 related articles for article (PubMed ID: 8738701)
1. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.
Okada T; Sakamoto T; Ishibashi T; Inomata H
Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):359-63. PubMed ID: 8738701
[TBL] [Abstract][Full Text] [Related]
2. Vogt-Koyanagi-Harada syndrome following injury-induced progressive vitiligo.
Gupta V; Gupta A; Bambery P; Radotra BD; Pandav SS
Indian J Ophthalmol; 2001 Mar; 49(1):53-5. PubMed ID: 15887718
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.
Inomata H; Sakamoto T
Curr Eye Res; 1990; 9 Suppl():35-40. PubMed ID: 1974489
[TBL] [Abstract][Full Text] [Related]
4. Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease.
Sakamoto T; Murata T; Inomata H
Arch Ophthalmol; 1991 Sep; 109(9):1270-4. PubMed ID: 1929956
[TBL] [Abstract][Full Text] [Related]
5. Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin?
Prignano F; Betts CM; Lotti T
J Electron Microsc (Tokyo); 2008 Jan; 57(1):25-31. PubMed ID: 18174263
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory vitiligo in Vogt-Koyanagi-Harada disease.
Tsuruta D; Hamada T; Teramae H; Mito H; Ishii M
J Am Acad Dermatol; 2001 Jan; 44(1):129-31. PubMed ID: 11148490
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic findings in the alopecia associated with Vogt-Koyanagi-Harada disease.
DiPreta EA; Smith KJ; Williams J; Skelton AH
J Cutan Med Surg; 2000 Jul; 4(3):156-60. PubMed ID: 11003722
[TBL] [Abstract][Full Text] [Related]
8. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
9. Vogt-Koyanagi-Harada disease: extensive vitiligo with prodromal generalized erythroderma.
Wong SS; Ng SK; Lee HM
Dermatology; 1999; 198(1):65-8. PubMed ID: 10026405
[TBL] [Abstract][Full Text] [Related]
10. [Intraocular inflammation and homeostasis of the eye].
Mochizuki M
Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
[TBL] [Abstract][Full Text] [Related]
11. [Vitiligo revealing Vogt -Koyanagi-Harada disease].
Amraoui ME; Zemmez Y; Bouhamidi A; Frikh R; Hjira N; Boui M
Pan Afr Med J; 2017; 27():220. PubMed ID: 28979622
[TBL] [Abstract][Full Text] [Related]
12. Successful Treatment of Vitiligo Associated with Vogt-Koyanagi-Harada Disease.
Bayer ML; Chiu YE
Pediatr Dermatol; 2017 Mar; 34(2):204-205. PubMed ID: 27981622
[TBL] [Abstract][Full Text] [Related]
13. Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders.
Egbeto IA; Garelli CJ; Piedra-Mora C; Wong NB; David CN; Robinson NA; Richmond JM
Front Immunol; 2020; 11():590558. PubMed ID: 33384688
[TBL] [Abstract][Full Text] [Related]
14. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival nodules associated with Vogt-Koyanagi-Harada disease.
Nakao K; Shimonagano Y; Doi N; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1383-6. PubMed ID: 17701198
[TBL] [Abstract][Full Text] [Related]
16. Immunopathologic study of Vogt-Koyanagi-Harada syndrome.
Chan CC; Palestine AG; Kuwabara T; Nussenblatt RB
Am J Ophthalmol; 1988 Jun; 105(6):607-11. PubMed ID: 3259837
[TBL] [Abstract][Full Text] [Related]
17. Peripheral T-cell activation in non-segmental vitiligo.
Mahmoud F; Abul H; al-Saleh Q; Haines D; Burleson J; Morgan G
J Dermatol; 1998 Oct; 25(10):637-40. PubMed ID: 9830261
[TBL] [Abstract][Full Text] [Related]
18. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
Abad S; Wieërs G; Colau D; Wildmann C; Delair E; Dhote R; Brézin AP; Kawakami Y; Coulie PG; van der Bruggen P
Mol Vis; 2014; 20():956-69. PubMed ID: 24991188
[TBL] [Abstract][Full Text] [Related]
19. Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome.
Kahn M; Pepose JS; Green WR; Miller J; Foos RY
Ophthalmology; 1993 Aug; 100(8):1191-8. PubMed ID: 8341501
[TBL] [Abstract][Full Text] [Related]
20. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Aosai F; Segawa K
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1210-6. PubMed ID: 2142146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
